000 01354 a2200409 4500
005 20250517071041.0
264 0 _c20170328
008 201703s 0 0 eng d
022 _a1536-4828
024 7 _a10.1097/MPA.0000000000000572
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhan, Tahsin M
245 0 0 _aElevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
_h[electronic resource]
260 _bPancreas
_c08 2016
300 _a1032-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aChromogranin A
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntestinal Neoplasms
_xblood
650 0 4 _aIntestine, Small
_xpathology
650 0 4 _aLiver Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuroendocrine Tumors
_xblood
650 0 4 _aPrognosis
650 0 4 _aRadioimmunoassay
_xmethods
650 0 4 _aRetrospective Studies
650 0 4 _aSensitivity and Specificity
700 1 _aGarg, Malika
700 1 _aWarner, Richard R P
700 1 _aUhr, Joshua H
700 1 _aDivino, Celia M
773 0 _tPancreas
_gvol. 45
_gno. 7
_gp. 1032-5
856 4 0 _uhttps://doi.org/10.1097/MPA.0000000000000572
_zAvailable from publisher's website
999 _c25557681
_d25557681